The New York Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-dark"]
Menu
Top Stories

: Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio

Read Time:7 Second

Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
0 0
Previous post The Margin: For Budweiser, Qatar World Cup has been a tale of tough logistics and quick thinking
Next post BNB price dips as Binance withdrawals take centre stage amid FUD

More Stories